Claimants Face 5pm ET Fri Deadline to Accept $8 Billion Settlement in J&J Suit, Ovarian Cancer Survivors Urge Others to Vote “Yes”

Exec Edge07-25

By Karen Roman The deadline to vote in favor of an $8 billion settlement in a class action lawsuit against Johnson & Johnson (NYSE: JNJ) regarding its talcum powder products is 5pm ET Friday, leaving ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2454851759?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/tKJnuQw3Wfxj0puSUqVKYg--~B/aD01NTM7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/exec_edge_220/649074dbe1019586d2efe48bfd4e7126","is_english":true,"pubTime":"2024-07-25 05:49","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2454851759","market":"us","top_or_hot":-1,"title":"Claimants Face 5pm ET Fri Deadline to Accept $8 Billion Settlement in J&J Suit, Ovarian Cancer Survivors Urge Others to Vote “Yes”","media":"Exec Edge","content":"<div>\n<p>By Karen Roman\nThe deadline to vote in favor of an $8 billion settlement in a class action lawsuit against Johnson & Johnson (NYSE: JNJ) regarding its talcum powder products is 5pm ET Friday, leaving ...</p>\n\n<a href=\"https://finance.yahoo.com/news/claimants-face-5pm-et-fri-214938543.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Claimants Face 5pm ET Fri Deadline to Accept $8 Billion Settlement in J&J Suit, Ovarian Cancer Survivors Urge Others to Vote “Yes”</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nClaimants Face 5pm ET Fri Deadline to Accept $8 Billion Settlement in J&J Suit, Ovarian Cancer Survivors Urge Others to Vote “Yes”\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-25 05:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/claimants-face-5pm-et-fri-214938543.html><strong>Exec Edge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>By Karen Roman\nThe deadline to vote in favor of an $8 billion settlement in a class action lawsuit against Johnson & Johnson (NYSE: JNJ) regarding its talcum powder products is 5pm ET Friday, leaving ...</p>\n\n<a href=\"https://finance.yahoo.com/news/claimants-face-5pm-et-fri-214938543.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4581","symbol_name":"高盛持仓","start_time":0,"source_url":"https://finance.yahoo.com/news/claimants-face-5pm-et-fri-214938543.html","article_id":"2454851759","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/tKJnuQw3Wfxj0puSUqVKYg--~B/aD01NTM7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/exec_edge_220/649074dbe1019586d2efe48bfd4e7126"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2454851759","pubTimestamp":1721857778,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"The deadline to vote in favor of an $8 billion settlement in a class action lawsuit against Johnson & Johnson  regarding its talcum powder products is 5pm ET Friday, leaving claimants just hours to act.The $8 billion plan has a net present value of $6.475 billion and will compensate for 25 years people who claim J&J’s powder products made them sick, putting an end to a long litigation process.  Under the plan, claimants may be paid $75,000 to $150,000 each.This historic solution covers current and future claimants, gives recovery to tens of thousands of harmed people and delivers an equitable compensation plan without lengthy and expensive trials. In over a decade of litigation, only 17 ovarian cancer cases have gone to trial. J&J has prevailed in 16 of the17 cases, with plaintiffs in those 16 cases recovering no money.Among the women supporting the proposal is Nonnie Hightower from Milwaukee, Wisconsin, an ovarian cancer survivor, who says the plan helps petitioners financially and pr","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4581":"高盛持仓","LU1585245621.USD":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","BK4504":"桥水持仓","LU0889566641.SGD":"FTSF - Templeton Shariah Global Equity A Acc SGD","LU1929549753.HKD":"FRANKLIN INCOME \"A\" (HKD) INC","LU1032955483.USD":"NORDEA 1 STABLE RETURN \"HB\" (USDHDG) ACC","BK4590":"PTP","LU0912757837.SGD":"JPMorgan Investment Funds - Global Income A (mth) SGD-H","IE00B7SZLL34.SGD":"Legg Mason ClearBridge - Value A Acc SGD-H","LU0792757196.USD":"TEMPLETON SHARIAH GLOBAL EQUITY FUND \"A\" (USD) ACC","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","ET":"Energy Transfer LP","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU1732800096.USD":"摩根大通环球收益基金A (irc)","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU1162221912.USD":"FRANKLIN INCOME \"A\" (USD) ACC","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","BK4532":"文艺复兴科技持仓","BK4144":"石油与天然气的储存和运输","BK4592":"伊斯兰概念","LU1261432733.SGD":"Fidelity World A-ACC-SGD","BK4561":"索罗斯持仓","LU1221951046.USD":"NORDEA 1 STABLE RETURN \"HM\" (USDHDG) INC","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","LU1935042991.SGD":"MANULIFE GF GLOBAL MULTI-ASSET DIVERSIFIED INCOME  \"AA\" (SGDHDG) INC","LU0234572021.USD":"高盛美国核心股票组合Acc","LU1221951129.SGD":"NORDEA 1 STABLE RETURN \"HM\" (SGDHDG) INC","BK4585":"ETF&股票定投概念","LU1267930813.SGD":"FRANKLIN TEMPLETON SHARIAH GLOBAL EQUITY \"AS\" (SGD) ACC","SG9999002224.SGD":"Allianz Global High Payout SGD","LU0345770308.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) ACC","LU2347655156.SGD":"JPMorgan Investment Funds - Global Income A (icdiv) SGD-H","LU0795875086.SGD":"JPMorgan Investment Funds - Global Income A (div) SGD","LU0466842654.USD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"A\" (USD) ACC","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","LU1196500208.SGD":"NORDEA STABLE RETURN \"HB\" (SGDHDG) ACC","LU1032466523.USD":"高盛全球多资产收益组合Acc","LU1059921491.USD":"NORDEA 1 GLOBAL STABLE EQUITY \"HB\" (USDHDG) ACC","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","BK4588":"碎股","LU1244550577.SGD":"FTIF - Franklin Global Multi-Asset Income A (Mdis) SGD-H1","JNJ":"强生","IE0034235303.USD":"PINEBRIDGE US RESEARCH ENHANCED CORE EQUITY \"A\" (USD) ACC","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","LU2133065610.SGD":"JPMorgan Investment Funds - Global Dividend A (mth) SGD","LU2602419157.SGD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"AC\" (SGD) ACC","SG9999001440.SGD":"United Global Dividend Equity Fund A SGD Dist","LU0345770993.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) INC","LU1244550494.USD":"FRANKLIN GLOBAL MULTI-ASSET INCOME \"A\" (USDHEDGED) ACC"},"translate_title":"索赔人面临美国东部时间周五下午5点接受强生诉讼80亿美元和解金的最后期限，卵巢癌幸存者敦促其他人投“赞成票”","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ET":1,"JNJ":1},"content_text":"By Karen Roman\nThe deadline to vote in favor of an $8 billion settlement in a class action lawsuit against Johnson & Johnson (NYSE: JNJ) regarding its talcum powder products is 5pm ET Friday, leaving claimants just hours to act. \nThe Ad Hoc Group of Counsel representing more than 77,500 people who say they were harmed by J&J’s talcum products including women diagnosed with ovarian cancer are encouraging claimants to support the settlement. Terms stipulate that 75% of all claimants voting must vote “yes” for the deal to move forward. More information about voting can be found at OfficialTalcClaims.com or by calling 1-888-431-4056.   \nThe $8 billion plan has a net present value of $6.475 billion and will compensate for 25 years people who claim J&J’s powder products made them sick, putting an end to a long litigation process.  Under the plan, claimants may be paid $75,000 to $150,000 each.\nThis historic solution covers current and future claimants, gives recovery to tens of thousands of harmed people and delivers an equitable compensation plan without lengthy and expensive trials. In over a decade of litigation, only 17 ovarian cancer cases have gone to trial. J&J has prevailed in 16 of the17 cases, with plaintiffs in those 16 cases recovering no money.\nAmong the women supporting the proposal is Nonnie Hightower from Milwaukee, Wisconsin, an ovarian cancer survivor, who says the plan helps petitioners financially and provides closure.\n“I used J&J baby powder my whole life. We put it on our babies, used it to smell better, even to slip into form-fitting clothes in the 90’s! Now I’m angry – for myself, for my daughter, and for my granddaughter,” Ms. Hightower said. “I wonder if I potentially harmed my own family by using baby powder on them. Battling cancer while raising my granddaughter was grueling. The bone pain from chemo was the worst thing ever. I’m supporting this settlement because there are many women waiting for justice, and financially, I need to. It might be our only choice, but it’s a step towards closure for all of us affected.”\n\nOvarian cancer survivor Rhonda McKey also supports the deal, saying it’s a way for J&J to supported harmed people. \n“Baby powder was a part of my life since I was literally a baby. Now, after battling cancer, my life has completely changed. I’ve gone from being self-employed to being on disability, unable to work as I did before,” Ms. McKey said. “Now, I’m not able to physically or financially help my family as I had wanted to and planned for. I support this settlement because I’ve seen companies take years to resolve these issues. If you’ve damaged people’s lives, you should help in some way. For those of us still here, it’s important that J&J follows through. We’ve lost quality time, and this settlement could help us regain some of that. I don’t want to just survive. I want to live. But it’s not just about me – it’s for all the women who have suffered, and for the families who have lost loved ones.” \n\n“It’s a highly democratic and efficient process that gives our clients a voice, for the first time, about whether the plan goes through or someone else decides for them,” said Anne Andrews, a member of the Ad Hoc Group and Founding and Managing Partner of Newport, CA-based law firm Andrews & Thornton. Ms. Andrews represents over 10,000 claimants, including Ms. McKey and Ms. Hightower.\n\nContact:\n\n\nExec Edge\n\n\nEditor@executives-edge.com","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"Policy And Regulatory","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.26.3","shortVersion":"4.26.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2454851759"}